Evidence map›Paper›PMID 23325272›Full record

ReviewJapanese journal of ophthalmology2013

Glycobiology of the ocular surface: mucins and lectins.

Pablo Argüeso

Abstract readReview
In one paragraph

Review in Japanese journal of ophthalmology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Article
  3. Bioinspired Lubricity from Surface Gel Layers.Langmuir : the ACS journal of surfaces and colloids · 2024
    Article
  4. Article
  5. Diabetes-Associated Hyperglycemia Causes Rapid-Onset Ocular Surface Damage.Investigative ophthalmology & visual science · 2023
    Article
  6. Article
  7. Article
  8. Biomechanics of a Plant-Derived Sealant for Corneal Injuries.Translational vision science & technology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Why Chain Length of Hyaluronan in Eye Drops Matters.Diagnostics (Basel, Switzerland) · 2020
    Review
  16. Review
  17. Review
  18. Review
  19. Tear-film-oriented diagnosis for dry eye.Japanese journal of ophthalmology · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Pablo ArgüesoSchepens Eye Research Institute and Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, 20 Staniford Street, Boston, MA 02114, USA. pablo_argueso@meei.harvard.edu

Funding

O-Glycans on Mucins at the Ocular SurfaceR01EY014847 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI ARGUESO, PABLO · 2003 to 2014
$4.0M
NEI NIH HHS R01 EY014847NEI NIH HHS R01EY014847
6 · The paper itself

Abstract

Glycosylation is an important and common form of posttranscriptional modification of proteins in cells. During the last decade, a vast array of biological functions has been ascribed to glycans because of a rapid evolution in glycomic technologies. Glycogenes that are highly expressed at the human ocular surface include families of glycosyltransferases, proteoglycans, and glycan degradation proteins, as well as mucins and carbohydrate-binding proteins, such as the galectins. On the apical glycocalyx, mucin O-glycans promote boundary lubrication, prevent bacterial adhesion and endocytic activity, and maintain epithelial barrier function through interactions with galectins. The emerging roles attributed to glycans are contributing to the appreciation of their biological capabilities at the ocular surface.

Indexed as

GlycomicsAnimalsBacterial AdhesionBiological TransportCorneaEpithelium, CornealGalectinsGlycocalyxGlycosylationGlycosyltransferasesHumansLectinsMucinsPolysaccharidesProtein Processing, Post-TranslationalGalectinsGlycosyltransferasesLectinsMucinsPolysaccharides

Identifiers

PMID23325272
PMCPMC3889467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.